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Abstract The vacuolar (H+)-ATPases (or V-ATPases) function
to acidify intracellular compartments in eukaryotic cells, playing
an important role in such processes as receptor-mediated
endocytosis, intracellular membrane traffic, protein degradation
and coupled transport. V-ATPases in the plasma membrane of
specialized cells also function in renal acidification, bone
resorption and cytosolic pH maintenance. The V-ATPases are
composed of two domains. The V1 domain is a 570-kDa
peripheral complex composed of 8 subunits (subunits A^H) of
molecular weight 70^13 kDa which is responsible for ATP
hydrolysis. The V0 domain is a 260-kDa integral complex
composed of 5 subunits (subunits a^d) which is responsible for
proton translocation. The V-ATPases are structurally related to
the F-ATPases which function in ATP synthesis. Biochemical
and mutational studies have begun to reveal the function of
individual subunits and residues in V-ATPase activity. A central
question in this field is the mechanism of regulation of vacuolar
acidification in vivo. Evidence has been obtained suggesting a
number of possible mechanisms of regulating V-ATPase activity,
including reversible dissociation of V1 and V0 domains, disulfide
bond formation at the catalytic site and differential targeting of
V-ATPases. Control of anion conductance may also function to
regulate vacuolar pH. Because of the diversity of functions of V-
ATPases, cells most likely employ multiple mechanisms for
controlling their activity.
z 1998 Federation of European Biochemical Societies.
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1. Function of V-ATPases
The vacuolar (H)-ATPases (or V-ATPases) are a family of
ATP-driven proton pumps responsible for acidi¢cation of a
variety of intracellular compartments in eukaryotic cells, in-
cluding clathrin-coated vesicles, endosomes, lysosomes, Golgi,
secretory vesicles and the central vacuoles of plants and lower
eukaryotes (for reviews, see [1^7]). We will begin with a brief
review of the function of V-ATPases in eukaryotic cells.
V-ATPases within endosomes function to provide the acidic
environment required for dissociation of internalized ligand-
receptor complexes that is necessary for receptor recycling to
the plasma membrane and delivery of dissociated ligands to
lysosomes [1]. Thus, recycling of receptors for such ligands as
low density lipoprotein (LDL), insulin and transferrin require
exposure to an acidic endosomal pH. In addition, endosomal
acidi¢cation appears to be required for budding of endosomal
carrier vesicles that function to transfer ligands from early to
late endosomes [8], a process that is sensitive to the speci¢c V-
ATPase inhibitor ba¢lomycin [9]. The V-ATPase dependent
step appears to be binding of coat proteins involved in vesicle
budding [10]. Finally, an acidic endosomal pH is utilized as a
signal to activate entry of certain pathogens into the cyto-
plasm of infected cells. Thus, exposure of in£uenza virus to
a low pH within endosomes induces formation of a fusion
pore between the viral and endosomal membranes that per-
mits entry of the viral RNA [11].
Vacuolar acidi¢cation plays an analogous role to that in the
endocytic pathway in intracellular targeting of newly synthe-
sized lysosomal enzymes from the Golgi to lysosomes [12].
Newly synthesized lysosomal enzymes are made with a man-
nose-6-phosphate recognition marker covalently attached that
allows them to bind to the Man-6-P receptor in the trans-
Golgi. These complexes are then delivered to an acidic, late
endosomal compartment where the low pH activates release
of the lysosomal enzymes and recycling of the Man-6-P re-
ceptors to the trans-Golgi. Although yeast does not possess a
Man-6-P receptor system, an acidic pH appears to play a
similar role in delivery of soluble proteins to the yeast vacuole
[13,14].
In secretory vesicles, such as synaptic vesicles and chromaf-
¢n granules, the V-ATPases provide the driving force for
coupled transport of small molecules, employing either the
membrane potential or the pH gradient generated [15]. A
similar function occurs in the yeast vacuole, where, for exam-
ple, Ca2 uptake is coupled to proton e¥ux [5]. The acidic pH
of digestive and secretory vesicles also plays an important role
in facilitating protein processing and degradation by acid-de-
pendent proteases.
V-ATPases in the plasma membrane of specialized cells
have also been shown to function in a variety of important
physiological processes. V-ATPases in the apical membrane of
renal intercalated cells function in renal acidi¢cation [16] while
V-ATPases in the plasma membrane of macrophages and neu-
trophils assist in maintaining a neutral cytoplasmic pH in the
face of acid loads [17]. In osteoclasts, V-ATPases are targeted
to a specialized domain of the plasma membrane that is in-
volved in bone resorption, thus assisting in degradation of the
bone matrix [18]. At least some tumor cells also appear to
target V-ATPases to the plasma membrane [19], where they
may function to provide an acidic extracellular environment
necessary for the activity of secreted lysosomal enzymes, thus
assisting in tumor metastasis. Finally, V-ATPases in the lu-
men of the midgut establish a positive exterior membrane
potential which serves to drive potassium e¥ux via an electro-
genic H/K antiporter [20].
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2. Structure and subunit function of V-ATPases
Our current structural model of the V-ATPase is shown in
Fig. 1. The V-ATPase is an 830-kDa multisubunit complex
composed of two functional domains. The V1 domain is a
570-kDa peripheral complex composed of eight subunits (sub-
units A^H) of molecular weight 70^13 kDa that functions in
ATP hydrolysis. The subunits are present in a stoichiometry
of A3B3C1D1E1FxGyHz [21], where the relative number of
copies of the F, G and H subunits has not yet been deter-
mined. The V0 domain is a 260-kDa integral domain com-
posed of ¢ve subunits (a, c, cP, cQ, d) of molecular weight
100^17 kDa that functions in proton translocation. The sub-
units are present in a stoichiometry of a1cQ1d1(c,cP)6. The sub-
unit names, molecular weights and genes encoding them in
yeast are shown in Table 1.
2.1. Structure and function of V1 subunits
The V-ATPases are known both from sequence homology
[22,23] and overall structure [21,24] to be related to the F-
ATPases (or ATP synthases), which are involved in ATP syn-
thesis in mitochondria, chloroplasts and bacteria [25^30]. The
recent X-ray crystal structure of the bovine mitochondrial F1
domain [31] has revealed that it is composed of a hexamer of
alternating alpha and beta subunits arranged around a central
stalk consisting of the highly alpha helical gamma subunit.
The six nucleotide binding sites are located at the interfaces
of the alpha and beta subunits, with the three catalytic sites
comprised mainly of beta subunit residues. Three additional
sites, termed ‘non-catalytic’ nucleotide binding sites, are lo-
cated primarily on the alpha subunits.
The V-ATPases also appear to contain both catalytic and
non-catalytic nucleotide binding sites, with the catalytic sites
located on the 70-kDa A subunits [32,33] and the non-cata-
lytic sites located on the 60-kDa B subunits [34,35]. There is
approximately 20^25% sequence identity between any pair of
the A, B, alpha and beta subunits [22,23], indicating that they
were derived from a common ancestral nucleotide binding
protein. Mutational studies of the yeast V-ATPase A subunit
[36^38] have identi¢ed a number of residues critical for activ-
ity, including E286, which corresponds to the glutamic acid
residue in the F-ATPase beta subunit that is postulated to act
in proton abstraction from the attacking water molecule, and
K263, which is located in the ‘glycine rich’ loop consensus
sequence and which is thought to interact with the negatively
charged phosphate groups of bound ATP. Aromatic residues
also appear to contribute to nucleotide binding at the catalytic
sites of the V-ATPase [38], possibly through direct interaction
with the adenine ring, as has been shown for the F-ATPase
[31]. Interestingly, the A subunit contains a large insert,
termed the ‘non-homologous’ region [22,23], which is not
present in the F-ATPase beta subunit.
Mutational analysis of the non-catalytic sites on the V-
ATPase has revealed that changes generally lead to much
less dramatic e¡ects on activity [38,39], although chemical
modi¢cation of these sites by BzATP does lead to inactivation
[34,35]. Interestingly, mutation of R483 on the A subunit,
which is postulated to be contributed to the non-catalytic
sites, leads to a time-dependent increase in activity following
addition of ATP [38], suggesting that occupancy of the non-
catalytic nucleotide binding sites may be required for optimal
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Fig. 1. Structural model of the V-ATPase. The V-ATPase complex
is composed of a 560-kDa peripheral V1 domain with the structure
A3B3C1D1E1FxGyHz (where the stoichiometry of the F, G and H
subunits is unknown) which is responsible for ATP hydrolysis and a
260-kDa integral V0 domain with the structure a1d1cQ1(c,cP)6 that is
responsible for proton translocation (see text for details). The sub-
unit composition of the second stalk (or stator) is uncertain, but
candidates include subunit G, H and the amino terminal domain of
the 100-kDa a subunit. CHO refers to carbohydrate covalently at-
tached to the 100-kDa subunit.
Table 1
Subunit composition of V-ATPases
Domain Subunit Coated vesicles Mr Yeast vacuole Mr Yeast gene Subunit function
V1 A 73 69 VMA1 Catalytic site, regulation (?)
B 58 57 VMA2 Non-catalytic site, targeting (?)
C 40 42 VMA5 Activity, assembly
D 34 32 VMA8 Activity, assembly
E 33 27 VMA4 Activity, assembly
F 14 14 VMA7 Activity, assembly
G 15 13 VMA10 Activity, assembly
H 50 54 VMA13 Activity (not assembly)
V0 a 100 95 VPH1/STV1 H transport, assembly, targeting
d 38 36 VMA6 Activity, assembly
c 17 17 VMA3 H translocation, DCCD site
cP 17 17 VMA11 H translocation, DCCD site (?)
cQ 19 23 VMA16 H translocation
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V-ATPase activity. It should be noted that the B subunit,
unlike the A, alpha and beta subunits, does not possess a
typical glycine rich loop consensus sequence [40], although
the sequence that corresponds to this region has been highly
conserved [41]. The function of the non-catalytic sites on the
F-ATPases also remains uncertain, although they have been
suggested to play a role in assembly of the F-ATPase complex
[42,43].
The remaining V1 subunits (C^H) have been shown from
both genetic analysis [44^49] and biochemical studies [50^54]
to play an important, although as yet unde¢ned, role in V-
ATPase activity. Two subunits (D and E) have been suggested
from secondary structure analysis ([55]; B. Bowman, personal
communication) as possible candidates to the alpha helical
gamma subunit of F1. The gamma subunit has been shown
to rotate within the alpha3beta3 hexamer of F1 during catal-
ysis [56^58], and this rotation is central to the mechanism of
energy coupling by F1F0. The 40-kDa C subunit of the V-
ATPases appears to be located on the outside of the V1 com-
plex based upon the stability of V1 formed in its absence [59],
and is thus unlikely to correspond to the V-ATPase homolog
of gamma. Interestingly, the C, D and E subunits can all be
crosslinked to the c subunit of the V0 domain [24], suggesting
that they play a role in attachment and coupling of the V1 and
V0 domains. Moreover, co-immunoprecipitation has demon-
strated a direct interaction between the C and E subunits [59].
Unlike the corresponding F1 domain, the V1 domain does not
carry out hydrolysis of MgATP [60], although a (Ca2)-ATP-
ase activity of V1 has been reported [50,51].
Increasing evidence has suggested the existence of a second
or peripheral stalk in both the V- and F-ATPases [61,62]. For
the F-ATPases, this peripheral stalk is believed to function as
a stator in holding the alpha3beta3 hexamer in place relative
to the a and b subunits of the F0 domain (see Section 3), and
appears to be comprised of the delta and b subunits [61].
Electron micrographs of the V-ATPases ([61,63]; Wilkens
and Forgac, unpublished results) suggest that the second stalk
in the V-ATPases may be much more extensive than for the
F-ATPases, more like a cu¡ covering three sides of the struc-
ture. While it is not yet certain what subunits constitute the
second stalk in the V-ATPases, the F, G and H subunits are
all possible candidates. In addition, the amino-terminal do-
main of the 100-kDa a subunit may serve to bind the F1
subunits and anchor this second stalk to the membrane.
2.2. Structure and function of the V0 subunits
The V0 domain is comprised of ¢ve di¡erent subunits (a,
c,cP,cQ and d). The c, cP and cQ subunits are termed proteolipid
subunits because of their highly hydrophobic character and
are homologous both to each other and to the 8-kDa c sub-
unit of F0 [64,26]. The F-ATPase c subunit, which contains
two transmembrane helices, has been shown by NMR to form
a hairpin in the membrane [65]. The V-ATPase c subunit,
which contains four transmembrane helices, appears to have
been derived by gene duplication and fusion from the F-ATP-
ase c subunit gene [66]. Both the F- and V-ATPase c subunits
have a single buried carboxyl group in the last transmembrane
helix which is the site of reaction with DCCD and is essential
for proton translocation through the F0 and V0 domains
[26,67]. The cP subunit has a similarly placed carboxyl group
while the cQ subunit has ¢ve transmembrane helices with the
critical carboxyl group present in the third [64]. Why the V-
ATPase requires three proteolipid subunits whereas the F-
ATPase functions with just one is unclear, but it has been
de¢nitively demonstrated by mutational analysis [64] that
each V-ATPase complex in yeast must contain at least one
copy of c, cP and cQ. The c and cP subunits are together present
in a stoichiometry of six copies per complex [21], thus con-
tributing the same number of transmembrane helices (24) as
the 12 copies of the F0 subunit c [26]. Electron micrographs
suggest that the F0 c subunits are arranged in a ring with the
one a and two b subunits to one side [68].
The 100-kDa a subunit is a transmembrane glycoprotein
possessing an amino terminal soluble domain and a carboxy
terminal hydrophobic domain containing 6^8 transmembrane
helices [69]. In yeast, the a subunit is encoded by two homol-
ogous genes (VPH1 and STV1), the products of which appear
to be targeted to di¡erent intracellular membranes [70,71].
Vph1p is targeted to the central vacuole while Stv1p appears
to be targeted to some other intracellular membrane, possibly
the Golgi or endosomes [71]. While the topography of the
100-kDa subunit has not been established, preliminary results
suggest that the amino terminal soluble domain may be ex-
posed to the cytoplasmic side of the membrane (Leng and
Forgac, unpublished results). Mutational analysis has identi-
¢ed a number of buried charged residues in the last two trans-
membrane segments which, while not absolutely essential for
activity, may play a role in proton translocation [72,73]. These
include E789 in the last transmembrane helix and H743 in the
penultimate membrane span. Thus, as with the a subunit of
F0 [74,75,26], the 100-kDa subunit may function to allow
protons to reach the buried carboxyl group of subunit c and
to leave this site for the opposite side of the membrane. The
100-kDa a subunit also appears to serve an important role in
assembly of the V-ATPase complex [73].
The 38-kDa d subunit is a cytoplasmically oriented poly-
peptide [76] that possesses no putative membrane spans but
appears to remain tightly associated with V0 through interac-
tions with other V0 subunits [77]. Unlike the F0 domain, the
free V0 domain does not normally function as a passive pro-
ton channel [78], although it can be induced to passively con-
duct protons by dissociation and reassembly [79] or acid treat-
ment [80].
3. Mechanism of V-ATPases
While the mechanism of neither the V- nor F-ATPases has
been established, there has recently been made signi¢cant
progress on the F-ATPase mechanism which is likely to be
relevant to the mechanism of the V-ATPases. One current
model for ATP coupled proton movement through F1F0 sug-
gests that conformational changes in the beta subunit associ-
ated with ATP dissociation force the central gamma subunit
to rotate within the alpha3beta3 hexamer [31]. Because gamma
appears to be rigidly attached to the ring of c subunits [61],
this also induces rotation of the ring of c subunits relative to
the a subunit. The a subunit, which is held rigid relative to the
alpha3beta3 hexamer by the b and delta subunits [61], is
thought to form two hemichannels which are separated
from each other in space [75,81]. For a proton to move
from one hemichannel to the other, it must bind to one of
the c subunit sites, rotate through the bilayer and dissociate at
the other hemichannel. Because the c subunit carboxyl must
be protonated to come in contact with the bilayer, this system
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allows the rotational energy released on ATP hydrolysis to
drive the formation of a linear proton gradient across the
membrane. The reverse process happens during ATP synthe-
sis. Interestingly, the V-ATPases possess only half the number
of protonateable sites in the ring of c subunits as the F-ATP-
ases [21], thus giving them a lower proton/ATP stoichiometry
which is optimal for ATP-dependent proton transport as op-
posed to ATP synthesis [82].
4. Assembly and targeting of the V-ATPases
The most complete information on assembly of the V-ATP-
ase complex has come from studies of the yeast enzyme. In
general it has been found that the absence of any of the V1
subunits results in the inability of the V1 domain to attach to
V0, although V1 subcomplexes have been observed under such
conditions and the assembly and targeting of the V0 domain is
unimpaired [83,84]. One exception is the H subunit (product
of the VMA13 gene), whose absence results in an inactive
complex in which V1V0 assembly still occurs, although the
resulting complex is less stable [49]. A second exception is
the F subunit (product of the VMA7 gene). In the absence
of a functional F subunit, even assembly of the V0 domain
appears to be defective, although some targeting of the 100-
kDa subunit still appears to occur [47]. Analysis of V1 sub-
complexes observed in strains lacking speci¢c V1 subunits [85^
87] has led to both the identi¢cation of a number of subunit
contacts and to a putative assembly pathway in vivo. For the
V0 domain, the absence of any of the V0 subunits results not
only in the absence of attachment of V1 to the membrane but
also in the failure of the remaining V0 subunits to correctly
assemble and target to the vacuole [83].
It has also been demonstrated in yeast that there are several
proteins (including the products of the VMA12, VMA21 and
VMA22 genes) which function in assembly of the V-ATPase
but do not form part of the ¢nal complex [88^90]. These
proteins appear to be resident ER proteins which form tran-
sient associations with speci¢c V-ATPase subunits and aid in
the assembly process. A recent report has suggested, however,
that the mammalian homolog to Vma21p may form part of
the mature chroma⁄n granule V-ATPase complex, although
the stoichiometry of this protein in the complex was not de-
termined [91].
Several subunits have been implicated to play a role in
intracellular targeting of the V-ATPases. As noted above,
the two isoforms of the 100-kDa subunit in yeast (Vph1p
and Stv1p) appear to be targeted to the central vacuole and
Golgi or endosomal membranes, respectively [70,71]. Two iso-
forms of the B subunit have been identi¢ed in mammalian
cells [41,92], one of which (the brain isoform) is expressed
ubiquitously while the other (the kidney isoform) is expressed
at high levels in cells (such as renal intercalated cells) which
are able to target V-ATPases to the plasma membrane. Two
isoforms of the A subunit have also been identi¢ed in plants,
one of which appears to be localized to the central vacuole
while the other localizes to the Golgi [93]. It is thus possible
that targeting information exists at several sites within the V-
ATPase complex.
5. Regulation of vacuolar acidi¢cation
One of the central questions concerning the V-ATPases is
the mechanism by which cells regulate vacuolar acidi¢cation.
A variety of studies indicate that cells are able to control the
pH of di¡erent intracellular compartments independently [94]
and evidence has been presented for a number of mechanisms
of controlling vacuolar pH.
Studies in yeast [95] have indicated that reversible dissocia-
tion of the V1 and V0 domains represents an important mech-
anism for directly controlling V-ATPase activity. Thus, glu-
cose deprivation causes a rapid dissociation of V-ATPases
from approximately 80% assembled to approximately 20%
assembled. This process is reversible and independent of
new protein synthesis. Evidence for a similar dissociation of
V1 and V0 domains during insect molting has been presented
[96], although reutilization of V1 domains has not been dem-
onstrated. The existence of separate pools of V1 and V0 do-
mains in mammalian cells [97] suggests that this may be a
widely employed mechanism, although the signals that trigger
dissociation and reassembly remain unclear.
A second mechanism that involves direct modi¢cation of V-
ATPase activity is covalent modi¢cation of the active site
through disul¢de bond formation [98,99]. We have demon-
strated that disul¢de bond formation between Cys254 of the
bovine A subunit (located in the glycine rich loop consensus
sequence) and Cys539 (located in the C-terminal domain of the
same A subunit) results in reversible inactivation of V-ATPase
activity [95]. Moreover, at least half of the V-ATPase in native
clathrin-coated vesicles exists in this inactive, disul¢de bonded
state [98]. We have suggested, therefore, that disul¢de bond
formation plays an important role in regulating V-ATPase
activity in vivo. Mutagenesis studies [36] suggest that this
mechanism may not be employed in controlling V-ATPase
activity in the Golgi, at least in yeast.
Several other mechanisms have also been suggested to play
a role in regulating V-ATPase activity in vivo. Both activator
[100,101] and inhibitor [102] proteins have been isolated from
tissue extracts, although their physiological role in controlling
V-ATPase activity has not yet been established. Uncoupling
of proton transport and ATPase activity has also been sug-
gested as a regulatory mechanism [103,104], and several con-
ditions have been shown to cause a change in the tightness of
coupling these two activities, including mild proteolysis [76]
and high concentrations of ATP [104], but the in vivo signals
that control coupling e⁄ciency remain uncertain. Control of
pump density through intracellular targeting of V-ATPases
has been shown to regulate proton transport across the apical
membrane of renal intercalated cells [16], but this mechanism
has not been shown to operate in regulation of pump density
in intracellular compartments. Finally, because V-ATPases
are electrogenic [104], vacuolar acidi¢cation can be controlled
through regulation of counterion conductance, which in most
cases in vivo appears to occur through the action of a parallel
chloride channel. The chloride channel in both endosomes
[105] and clathrin-coated vesicles [106] has been shown to be
regulated by PKA-dependent phosphorylation, suggesting
these channels may represent an important control point for
vacuolar pH. Because of the diversity of functions that V-
ATPases serve in eukaryotic cells, it is likely that the mecha-
nisms for regulation of vacuolar acidi¢cation in vivo will re-
£ect a comparable complexity.
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